Cargando…
Atypical Course of SarsCov-2 Infection in a Patient with Multiple Myeloma Treated with Autologous Stem Cell Transplantation
Covid-19 infection has more relevant consequences in frail and comorbid patients, but little is known about its course in patients with hematologic malignancies. In this report, we would like to present the case of a patient with multiple myeloma treated with recent autologous bone marrow stem cell...
Autores principales: | Isaia, Gianluca, Valerio, Silvia, Oliva, Stefania, Brunetti, Enrico, Bo, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452944/ https://www.ncbi.nlm.nih.gov/pubmed/37637765 http://dx.doi.org/10.18502/ijhoscr.v17i2.12652 |
Ejemplares similares
-
(590) Sars_Cov2 Experience in the West Australian Heart Transplant Population
por: House, C., et al.
Publicado: (2023) -
P1353: EFFICACY OF SARSCOV2 VACCINATION IN PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION. A MULTICENTER EXPERIENCE
por: Stirparo, L., et al.
Publicado: (2022) -
Exogenous melatonin as potential adjuvant in anti-SarsCov2 vaccines
por: Maestroni, Georges
Publicado: (2020) -
Autologous transplant for myeloma: when the old meets the new
por: Gay, Francesca, et al.
Publicado: (2017) -
(585) Impact of the SarsCov2 Booster Dose on Clinical Events in Heart Transplant Patients in Galicia. INMU TC Study
por: Enriquez, D., et al.
Publicado: (2023)